Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1
Xiong Xie(Chinese Academy of Sciences), Hong Liu(North West Agriculture and Forestry University), Maolin Shao(ShanghaiTech University), Wei Xu(Beijing Geriatric Hospital), Wenhao Dai(Chinese Academy of Sciences), Zihe Rao(Nankai University), Shulei Hu(Chinese Academy of Sciences), Changyue Yu(Chinese Academy of Sciences), Yan Zhu(Chinese Academy of Sciences), Jingjing Peng(China Agricultural University), Leike Zhang(Chinese Academy of Sciences), Yao Zhao(Shenzhen Third People’s Hospital), Qiaoshuai Lan(Chinese University of Hong Kong), Xianglei Zhang(ShanghaiTech University), Fang Bai(ShanghaiTech University), Shibo Jiang(Shanghai Medical College of Fudan University), Shuai Xia(Shanghai Medical College of Fudan University), Mingyue Zheng(Shanghai Library), Jinyi Zhao(ShanghaiTech University), Dakota Ma(Dartmouth College), Zhen Ge(Beijing Institute of Technology), Jiang Wang(Zhengzhou Central Hospital), Lu Lu(Shanghai Medical College of Fudan University), Jian Li(Sir Run Run Shaw Hospital), Yumin Zhang(Huazhong University of Science and Technology), Keke Zhang(Jinan University), Sulin Zhang(Shanghai Institute of Materia Medica), Lu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Haitao Yang(Fujian Medical University), Ruxue Zhang(Chinese Academy of Sciences), Gengfu Xiao(Chinese Academy of Sciences)
Cited by 23
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400